DUQUESNE FAMILY OFFICE LLC
Q2 2025 Form 13-F
NEW YORK, NEW YORK
CIK 0001536411
· Institutional investment manager
$4.1B Reported Value Total
Reported value
$4.1B
Quarter over quarter
+21.3%
Holdings
65
Top-10 concentration
50.5%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Sue Meng
General Counsel
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2025 13F record
Q2 2025 13F filing summary
| Period of report | June 30, 2025 |
|---|---|
| Filed | August 15, 2025 |
| Form | 13F-HR |
| Reported value | $4.1B |
| Positions | 65 |
| Change in reported value | +33.1% |
| New positions | 31 |
| Exited positions | 15 |
| Position turnover | 57.5% |
| Top-10 concentration | 50.5% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
86 | $5.2B |
|
Q1 2026 13F
Filed May 15, 2026
|
65 | $3.4B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
58 | $4.5B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
62 | $4.1B |
|
Q2 2025 13F
Filed Aug 15, 2025
|
65 | $4.1B |
|
Q1 2025 13F
Filed May 15, 2025
|
49 | $3.1B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
74 | $3.7B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
72 | $3.0B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
63 | $2.9B |
|
Q1 2024 13F
Filed May 15, 2024
|
72 | $4.4B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
50 | $3.4B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
41 | $2.8B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
53 | $2.9B |
|
Q1 2023 13F
Filed May 15, 2023
|
48 | $2.3B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
57 | $2.0B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
63 | $1.8B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
42 | $1.4B |
|
Q1 2022 13F
Filed May 16, 2022
|
49 | $2.3B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
48 | $2.8B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
48 | $3.1B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | NTRA Natera Inc | $521.2M | 12.8% |
| 2 | TEVA Teva Pharmaceutical Inds Ltd | $267.6M | 6.57% |
| 3 | INSM Insmed Inc | $226.8M | 5.57% |
| 4 | WWD Woodward Inc | $208.1M | 5.11% |
| 5 | TSM Taiwan Semiconductor Mfg Ltd | $173.3M | 4.26% |
| 6 | PM Philip Morris Intl Inc | $148.6M | 3.65% |
| 7 | MELI Mercadolibre Inc | $140.4M | 3.45% |
| 8 | ENTG Entegris Inc | $132.7M | 3.26% |
| 9 | CPNG Coupang Inc | $123.0M | 3.02% |
| 10 | FLUT Flutter Entmt Plc | $115.8M | 2.84% |
| 11 | COHR Coherent Corp | $103.3M | 2.54% |
| 12 | DOCU Docusign Inc | $100.5M | 2.47% |
| 13 | MSFT Microsoft Corp | $99.9M | 2.45% |
| 14 | ROKU Roku Inc | $96.7M | 2.38% |
| 15 | VRNA Verona Pharma Plc | $94.8M | 2.33% |
| 16 | LLY Eli Lilly & Co | $78.5M | 1.93% |
| 17 | WBD Warner Bros Discovery Inc | $74.9M | 1.84% |
| 18 | EQT Eqt Corp | $73.1M | 1.79% |
| 19 | IWM C Ishares Tr | $72.3M | 1.78% |
| 20 | C Citigroup Inc | $56.7M | 1.39% |
Values as reported on the Q2 2025 Form 13F. Every position is in the holdings table below.